

Cover Story
Real-world Evidence
By Matthew Bin Han Ong
Routine screening procedures for breast, colon, and cervical cancers in the first half of 2021 have failed to recover, falling by about a third below historical baselines, even as Americans are resuming normal activities.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- Otis Brawley looks back on a year of great science and greater challenges
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Twitter star Vinay Prasad retires @VinayPrasadMD
- AI will determine Medicare prior authorizations in six states under new pilot program
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park















